Comparing genetic mutations of first-degree relatives with appendiceal pseudomyxoma peritonei may explain clinical outcomes and disease pathogenesis. Molecular profiling of mucinous tumors may identify improved treatments to traditional chemotherapy.
CITATION STYLE
King, M. C., Munoz-Zuluaga, C., Ledakis, P., Studeman, K., Sittig, M., Gushchin, V., & Sardi, A. (2020). Germline and somatic genetic alterations in two first-degree relatives with appendiceal low-grade mucinous carcinoma peritonei. Clinical Case Reports, 8(12), 3168–3177. https://doi.org/10.1002/ccr3.3338
Mendeley helps you to discover research relevant for your work.